ACHV Achieve Life Sciences, Inc. gains 16% Mar 22, 2019
Posted By: Rajesh Srivastava - Friday, March 22, 2019
OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.http://www.priceseries.com/trade/ACHV-Achieve-Life-Sciences-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2019031420190322.html
About Rajesh Srivastava
Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment